多发性骨髓瘤-话题@MedSci

#多发性骨髓瘤#

50篇内容 | 4394人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=907272, encodeId=66e790e272ee, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>, objectTitle=Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略, objectType=article, longId=204413, objectId=892c204413da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201211/1607657347001_2467676.PNG, objectUrl=/article/show_article.do?id=892c204413da, replyNumber=0, likeNumber=165, createdTime=2020-12-12, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=892c204413da, moduleTitle=Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=892c204413da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=907086, encodeId=678b90e086ba, content=<a href='/topic/show?id=f7934849981' target=_blank style='color:#2F92EE;'>#帕比司他#</a>用于<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>, objectTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, objectType=article, longId=204420, objectId=fbc5204420da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/rheumatoid_arthritis_s12_citrulline_test.jpg, objectUrl=/article/show_article.do?id=fbc5204420da, replyNumber=0, likeNumber=116, createdTime=2020-12-11, rootId=0, userName=lifefamily, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbc5204420da, moduleTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbc5204420da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=905080, encodeId=d1aa90508001, content=<a href='/topic/show?id=21d764465c7' target=_blank style='color:#2F92EE;'>#沙利度胺#</a>及其衍生物已被广泛用于治疗恶性<a href='/topic/show?id=66c489335e5' target=_blank style='color:#2F92EE;'>#血液肿瘤#</a>和<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>，还用于很多实体瘤，如肝癌等，作为抗血管新生和免疫调节剂，作用不亚于贝伐单抗，对成人而言，安全性也是相当不错的。, objectTitle=沙利度胺可防止神经细胞死亡, objectType=article, longId=132282, objectId=ab43132282ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201803/20180313112158362.jpg, objectUrl=/article/show_article.do?id=ab43132282ae, replyNumber=0, likeNumber=204, createdTime=2020-12-05, rootId=0, userName=lifefamily, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab43132282ae, moduleTitle=沙利度胺可防止神经细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab43132282ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=881849, encodeId=27bb88184911, content=<a href='/topic/show?id=ff1c3654ebf' target=_blank style='color:#2F92EE;'>#卡非佐米#</a> 较 <a href='/topic/show?id=5ccae366556' target=_blank style='color:#2F92EE;'>#硼替佐米#</a>虽然是新一代药物，但是对于<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>而言，要比出差异并不容易。因此，大家不必过度迷信新药，老药在联合方案中，往往仍然是不错的。, objectTitle=Lancet oncol：卡非佐米 vs 硼替佐米联合来那度胺+地塞米松治疗多发性骨髓瘤的疗效, objectType=article, longId=200125, objectId=9b81200125b7, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=9b81200125b7, replyNumber=0, likeNumber=197, createdTime=2020-09-01, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b81200125b7, moduleTitle=Lancet oncol：卡非佐米 vs 硼替佐米联合来那度胺+地塞米松治疗多发性骨髓瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b81200125b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=807334, encodeId=93b780e334ff, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>, objectTitle=Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤, objectType=article, longId=199134, objectId=f4861991340d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020810/1597030298455_2110107.PNG, objectUrl=/article/show_article.do?id=f4861991340d, replyNumber=0, likeNumber=171, createdTime=2020-08-10, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4861991340d, moduleTitle=Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4861991340d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803190, encodeId=f6ba803190c5, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>延长生命相当厉害, objectTitle=Lancet：卡非佐米、达雷木单抗联合地塞米松治疗复发或难治性多发性骨髓瘤, objectType=article, longId=197722, objectId=54d019e7223c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020718/1595037872691_2051781.jpg, objectUrl=/article/show_article.do?id=54d019e7223c, replyNumber=0, likeNumber=152, createdTime=2020-07-18, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54d019e7223c, moduleTitle=Lancet：卡非佐米、达雷木单抗联合地塞米松治疗复发或难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54d019e7223c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=799947, encodeId=ed48e99947a0, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>mark, objectTitle=Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失, objectType=article, longId=196564, objectId=f010196564d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-checking-patient-x-ray-film-PY8MED5.jpg, objectUrl=/article/show_article.do?id=f010196564d8, replyNumber=0, likeNumber=159, createdTime=2020-06-26, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f010196564d8, moduleTitle=Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f010196564d8)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

多发性骨髓瘤

2020-05-29

Nebula-Qin (审核中...)

前往app查看评论内容

#多发性骨髓瘤#

Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略

2020-12-12

lifefamily (审核中...)

前往app查看评论内容

#帕比司他#用于#多发性骨髓瘤#

Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性

2020-12-11

lifefamily (审核中...)

前往app查看评论内容

#沙利度胺#及其衍生物已被广泛用于治疗恶性#血液肿瘤#和#多发性骨髓瘤#，还用于很多实体瘤，如肝癌等，作为抗血管新生和免疫调节剂，作用不亚于贝伐单抗，对成人而言，安全性也是相当不错的。

沙利度胺可防止神经细胞死亡

2020-12-05

lovetcm (审核中...)

前往app查看评论内容

#卡非佐米# 较 #硼替佐米#虽然是新一代药物，但是对于#多发性骨髓瘤#而言，要比出差异并不容易。因此，大家不必过度迷信新药，老药在联合方案中，往往仍然是不错的。

Lancet oncol：卡非佐米 vs 硼替佐米联合来那度胺+地塞米松治疗多发性骨髓瘤的疗效

2020-09-01

lovetcm (审核中...)

前往app查看评论内容

#多发性骨髓瘤#

Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤

2020-08-10

lovetcm (审核中...)

前往app查看评论内容

#多发性骨髓瘤#延长生命相当厉害

Lancet：卡非佐米、达雷木单抗联合地塞米松治疗复发或难治性多发性骨髓瘤

2020-07-18

(审核中...)

前往app查看评论内容

#多发性骨髓瘤#mark

Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失

2020-06-26

科室
- - 订阅+
  - 更多科室
工具
服务